Abstract
Lung cancer is rated with the highest incidence and mortality every year compared with other forms of cancer, therefore early detection and diagnosis is essential. Artificial Neural Networks (ANNs) are “artificial intelligence” software which have been used to assess a few prognostic situations. In this study, a database containing 193 patients from Diagnostic and Monitoring of Tuberculosis and Illness of Lungs Ward in Kuyavia and Pomerania Centre of the Pulmonology (Bydgoszcz, Poland) was analysed using ANNs. Each patient was described using 48 factors (i.e. age, sex, data of patient history, results from medical examinations etc.) and, as an output value, the expected presence of lung cancer was established. All 48 features were retrospectively collected and the database was divided into a training set (n=97), testing set (n=48) and a validating set (n=48). The best prediction score of the ANN model (MLP 48-9-2) was above 0.99 of the area under a receiver operator characteristic (ROC) curve. The ANNs were able to correctly classify 47 out of 48 test cases. These data suggest that Artificial Neural Networks can be used in prognosis of lung cancer and could help the physician in diagnosis of patients with the suspicion of lung cancer.
[1] Jemal A., Siegel R., Xu J., Ward E., Cancer Statistics 2010, Ca. Cancer. J. Clin., 2010, 60, 277–300 http://dx.doi.org/10.3322/caac.2007310.3322/caac.20073Search in Google Scholar
[2] Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012, CA Cancer J Clin., 2012 62, 10–29 http://dx.doi.org/10.3322/caac.2013810.3322/caac.20138Search in Google Scholar
[3] Szczuka I., Roszkowski-Ślisz K., Lung cancer in Poland in 1970–2004, Pneumonol. Alergol. Pol., 2008, 76, 19–28 10.5603/ARM.27922Search in Google Scholar
[4] Ahmed K., Emran A.A., Jesmin T., Early detection of lung cancer risk using data mining, Asian Pac. J.Cancer Prev., 2013, 14, 595–598 http://dx.doi.org/10.7314/APJCP.2013.14.1.59510.7314/APJCP.2013.14.1.595Search in Google Scholar
[5] Flores J.M., Herrera E., Leal G, Artificial Neural Network-Based Serum Biomarkers Analysis Improves Sensitivity in the Diagnosis of Lung Cancer, IFMBE Proceedings 2013, 33, 882–885 http://dx.doi.org/10.1007/978-3-642-21198-0_22410.1007/978-3-642-21198-0_224Search in Google Scholar
[6] Bishop C.M., Neural networks for pattern recognition, New York, NY: Oxford University Press 1995. Search in Google Scholar
[7] Dayhoff J.E., DeLeo J.M., Artificial neural networks: opening the black box, Cancer, 2001, 91, 1615–1635 http://dx.doi.org/10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-LSearch in Google Scholar
[8] Cross S.S., Harrison F.H., Kennedy R.L., Introduction to neural networks. Lancet, 1995, 346, 1075–1079 http://dx.doi.org/10.1016/S0140-6736(95)91746-210.1016/S0140-6736(95)91746-2Search in Google Scholar
[9] Baxt W.G., Application of artificial neural networks to clinical medicine, Lancet, 1995, 346, 1135–1138 http://dx.doi.org/10.1016/S0140-6736(95)91804-310.1016/S0140-6736(95)91804-3Search in Google Scholar
[10] Amato F., López A., Peña-Méndez E. M., Artificial neural networks in medical diagnosis, J. Appl. Biomed., 2013, 11, 47–58 http://dx.doi.org/10.2478/v10136-012-0031-x10.2478/v10136-012-0031-xSearch in Google Scholar
[11] Alkim E., Gürbüz E., Kiliç E., A fast and adaptiveautomated disease diagnosis method with an innovative neural network model, Neur. Networks, 2012, 33, 88–96 http://dx.doi.org/10.1016/j.neunet.2012.04.01010.1016/j.neunet.2012.04.010Search in Google Scholar PubMed
[12] Atkov O., Gorokhova S., Sboev A., Coronary heart disease diagnosis by artificial neural networks including genetic polymorphisms and clinical parameters, J. Cardiol., 2012, 59, 190–194 http://dx.doi.org/10.1016/j.jjcc.2011.11.00510.1016/j.jjcc.2011.11.005Search in Google Scholar PubMed
[13] Buciński A., Bączek T., Kaliszan R., Nasal A., Krysiński J., Załuski J., Artificial Neural Network Analysis of Patient and Treatment Variables as a Prognostic Tool in Breast Cancer after Mastectomy, Adv. Clin. Exp. Med., 2005, 14, 973–979 Search in Google Scholar
[14] Patel J.L., Goyal R.K., Application of artificial neural networks in medicinal science, Curr. Clin. Pharmacol., 2007, 2, 217–226 http://dx.doi.org/10.2174/15748840778166881110.2174/157488407781668811Search in Google Scholar PubMed
[15] Atkov O., Gorokhova S., Sboev A., Coronary heart disease diagnosis by artificial neural networks including genetic polymorphisms and clinical parameters, J. Cardiol., 2012, 59, 190–194 http://dx.doi.org/10.1016/j.jjcc.2011.11.00510.1016/j.jjcc.2011.11.005Search in Google Scholar PubMed
[16] Uğuz H., A biomedical system based on artificial neural network and principal component analysis for diagnosis of the heart valve diseases., J. Med. Syst., 2012, 36, 61–72 http://dx.doi.org/10.1007/s10916-010-9446-710.1007/s10916-010-9446-7Search in Google Scholar PubMed
[17] Esteva H., Bellotti M., Marchevsky A.M., Neural networks for the estimation of prognosis in lung cancer, In: Naguib R.N., Sherbet G.V. eds. Artificial neural networks in cancer diagnosis, prognosis and patient management. Boca Raton: CRC Press, 2001: 29–37 http://dx.doi.org/10.1201/9781420036381.ch410.1201/9781420036381.ch4Search in Google Scholar
[18] Bucinski A., Marszall M.P., Krysinski J., Lemieszek A., Zaluski A., Contribution of artificial intelligence to the knowledge of prognostic factors in Hodgkin’s lymphoma, Eur. J. Cancer Prev., 2010, 19, 308–312 http://dx.doi.org/10.1097/CEJ.0b013e32833ad35310.1097/CEJ.0b013e32833ad353Search in Google Scholar PubMed
[19] Cinar M., Engin M., Egin E. Z., Atesci Y. Z., Early prostate cancer diagnosis by using artificial neural networks and support vector machines, Expert Systems with Applications, 2009, 36, 6357–6361 http://dx.doi.org/10.1016/j.eswa.2008.08.01010.1016/j.eswa.2008.08.010Search in Google Scholar
[20] Marszałł M.P., Krysiński J., Sroka W. D., Nyczak Z., Stefanowicz M., Waśniewski T., Romaszko J., Buciński A. ANN as a prognostic tool after treatment of non-seminoma testicular cancer, Central Eur. J. Med. 2012, 7, 672–679 http://dx.doi.org/10.2478/s11536-012-0027-710.2478/s11536-012-0027-7Search in Google Scholar
[21] Bączek T., Buciński A., Ivanov A.R., Kaliszan R., Artificial neural network analysis for evaluation of peptide MS/MS spectra in proteomics, Anal. Chem., 2004, 76, 1726–1732 http://dx.doi.org/10.1021/ac030297u10.1021/ac030297uSearch in Google Scholar PubMed
[22] Koba M., Application of artificial neural networks for the prediction of antitumor activity of a series of acridinone derivatives, Med. Chem., 2012, 8, 309–319 http://dx.doi.org/10.2174/15734061280078665110.2174/157340612800786651Search in Google Scholar PubMed
[23] Luenberger D.G., Ye Y., Linear and nonlinear programming, International Series in Operations Research & Management Science 116 (Third ed.), New York, Springer, 2008, pp. xiv+546 10.1007/978-0-387-74503-9Search in Google Scholar
[24] Knyazev, A.V., Lashuk I., Steepest Descent and Conjugate Gradient Methods with Variable Preconditioning, SIAM J. Matrix Anal. A, 2008, 29, 1267–1280 http://dx.doi.org/10.1137/06067529010.1137/060675290Search in Google Scholar
[25] Chen T.M., Kuschner W.G., Non-tobacco related lung carcinogens. Lung cancer principle and practice, In: Harvey P. et al, editors. 3rd ed, Lippincot Williams and Wilkins: 2005. p. 61–73 Search in Google Scholar
[26] Bij S., Hendrik Koffijberg H., Lenters V., Lung cancer risk at low cumulative asbestos exposure: meta-regression of the exposure-response relationship, Cancer Cause. Control, 2013, 24, 1–12 http://dx.doi.org/10.1007/s10552-012-0107-710.1007/s10552-012-0107-7Search in Google Scholar PubMed
[27] Alberg A.J., Samet J.M., Epidemiology of lung cancer, Chest, 2003, 123, 21S–49S http://dx.doi.org/10.1378/chest.123.1_suppl.21S10.1378/chest.123.1_suppl.21SSearch in Google Scholar PubMed
[28] Shopland D., Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking, Environ. Health. Prospect., 1995, 103, 131–142 http://dx.doi.org/10.1289/ehp.95103s813110.1289/ehp.95103s8131Search in Google Scholar PubMed PubMed Central
[29] Doll R., Peto R., Boreham J., Sutherland I., Mortality from cancer in relation to smoking: 50 years observations on British doctors, Br. J. Cancer, 2005, 92, 426–429 http://dx.doi.org/10.1038/sj.bjc.660245010.1038/sj.bjc.6602450Search in Google Scholar PubMed PubMed Central
[30] De Matteis S., Consonni D., Pesatori A.C., Are women who smoke at higher risk for lung cancer than men who smoke? Am. J. Epidemiol., 2013, 177, 601–612 http://dx.doi.org/10.1093/aje/kws44510.1093/aje/kws445Search in Google Scholar PubMed PubMed Central
[31] Sutedja G., New techniques for early detection of lung cancer, Eur. Respir. J., 2003, 21, 57–66 http://dx.doi.org/10.1183/09031936.03.0040530310.1183/09031936.03.00405303Search in Google Scholar PubMed
© 2014 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
